Clinical Trial Update: Trial of Mirtazapine for Depression in IBD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating mirtazapine for depression in individuals with inflammatory bowel disease. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Major Depressive Disorder

Drugs mentioned

• mirtazapine (mirtazapine)

Snippet

Sponsor: King's College London | Conditions: Major Depressive Disorder, Inflammatory Bowel Diseases | Phase 2 | Status: RECRUITING